Blog Posts

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.
The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder 

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Loosens 340B Contract Pharmacy Restrictions in Five More States

Sumitomo Pharma America loosened or ended its 340B contract pharmacy restrictions in an additional five states.
Drugmaker Sumitomo Pharma America (SMPA) is partially or fully exempting providers in five additional states from its 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Missouri Become Eighth State to Enact 340B Contract Pharmacy Access Law After Governor Declines to Act on Bill

Missouri will become the eighth state to enact a 340B contract pharmacy access law when S.B.751 officially takes effect Aug. 28.
Missouri will become the eighth state to prohibit drug manufacturer 340B contract pharmacy restrictions after Gov. Mike Parson (R) announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Upcoming Federal Elections Will Significantly Impact 340B Legislative Agenda, Say 340B Hospital Lobbyist, Drug Industry Analyst

Tom O’Donnell, senior vice president of government relations at 340B Health, and Michael McCaughan, co-founder of Provision Policy, gave a July 10 address at the 340B Coalition summer conference.
The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates March on Capitol Hill to ‘Defend 340B’ Amid D.C. Heat Wave

More than 60 advocates marched on Capitol Hill amid a heat wave in Washington, D.C. for the third annual "Defend 340B March" on July 10.
More than sixty 340B advocates braved an excessive heat warning in the nation’s capital yesterday afternoon for the third annual [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Navigating State-Level Regulations to Safeguard Your 340B Program

SPONSORED CONTENT

While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of complexity. Covered entities (CEs) must be vigilant in understanding how these state laws can impact their operations to avoid potential compliance pitfalls. We have outlined a few

Read More »

Matsui’s 340B PATIENTS Act Gains 5 Democratic Co-Sponsors Ahead of 340B Health Lobby Days

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pharma-Linked Conservative Nonprofit Launches Ad Campaign to ‘Stop the Feeding Frenzy’ in 340B

The Council for Citizens Against Government Waste has launched a new ad campaign that criticizes the 340B program.
An anti-government waste group with ties to the drug industry is urging lawmakers to “stop the feeding frenzy” in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live